Overview

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants

Status:
Completed
Trial end date:
2019-12-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the PK, safety and tolerability of phenylacetate and benzoate after intravenous administration of TAK-123 in Japanese healthy adult male participants.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda